Xu CW - Search Results

1

Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.

Xu CW, Wang WX, Wu MJ, Zhu YC, Zhuang W, Lin G, Du KQ, Huang YJ, Chen YP, Chen G, Fang MY. Xu CW, et al. Thorac Cancer. 2017 Sep;8(5):417-422. doi: 10.1111/1759-7714.12455. Epub 2017 Jun 7. Thorac Cancer. 2017. PMID: 28590585 Free PMC article.

2

Detection of Her-2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry.

Zhu GJ, Xu CW, Fang MY, Zhang YP, Li Y. Zhu GJ, et al. Among authors: xu cw. Exp Ther Med. 2014 Nov;8(5):1501-1507. doi: 10.3892/etm.2014.1982. Epub 2014 Sep 22. Exp Ther Med. 2014. PMID: 25289049 Free PMC article.

3

A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients.

Fang M, Xu C, Wu J, Zhang Y, He C. Fang M, et al. J Cancer Res Ther. 2014 Nov;10 Suppl:C150-4. doi: 10.4103/0973-1482.145847. J Cancer Res Ther. 2014. PMID: 25450274 Free article.

4

A comparison of consistency of detecting c-MET gene amplification in peripheral blood and tumor tissue of nonsmall cell lung cancer patients.

Chen D, Xu C, Wu J, Zhang Y, Fang M. Chen D, et al. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C63-7. doi: 10.4103/0973-1482.163843. J Cancer Res Ther. 2015. PMID: 26323927 Free article.

5

OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.

Li H, Miao Q, Xu CW, Huang JH, Zhou YF, Wu MJ. Li H, et al. Among authors: xu cw. J Korean Med Sci. 2016 Aug;31(8):1215-23. doi: 10.3346/jkms.2016.31.8.1215. Epub 2016 Jun 3. J Korean Med Sci. 2016. PMID: 27478331 Free PMC article.

6

Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature.

Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J. Zhu YC, et al. Among authors: xu cw. Onco Targets Ther. 2016 Jul 15;9:4301-5. doi: 10.2147/OTT.S109415. eCollection 2016. Onco Targets Ther. 2016. PMID: 27486332 Free PMC article.

7

Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis.

Lin L, Chen GY, Xu CW, Wang HY, Wu YF, Fang MY. Lin L, et al. Among authors: xu cw. J Cancer Res Ther. 2016 Dec;12(Supplement):C191-C198. doi: 10.4103/0973-1482.200601. J Cancer Res Ther. 2016. Retraction in: J Cancer Res Ther. 2017 Jan-Mar;13(1):156. doi: 10.4103/0973-1482.206243 PMID: 28230016 Free article. Retracted.

8

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report.

Zhu YC, Liao XH, Wang WX, Xu CW, Zhuang W, Zhong LH, Du KQ, Chen YP, Chen G, Fang MY. Zhu YC, et al. Among authors: xu cw. Onco Targets Ther. 2017 Jun 27;10:3187-3192. doi: 10.2147/OTT.S139718. eCollection 2017. Onco Targets Ther. 2017. PMID: 28721068 Free PMC article.

9

Hemangioma of the Rib: A Rare Case Report and Literature Review.

Zhu YC, Lin XP, Lu Y, Wang WX, Du KQ, Ye XQ, Zong C, Xu CW. Zhu YC, et al. Among authors: xu cw. Open Med (Wars). 2017 Aug 10;12:257-260. doi: 10.1515/med-2017-0038. eCollection 2017. Open Med (Wars). 2017. PMID: 28828408 Free PMC article.

10

Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review.

Xu CW, Wang WX, Huang RF, He C, Liao XH, Zhu YC, Du KQ, Zhuang W, Chen YP, Chen G, Fang MY. Xu CW, et al. Thorac Cancer. 2017 Nov;8(6):714-719. doi: 10.1111/1759-7714.12496. Epub 2017 Aug 28. Thorac Cancer. 2017. PMID: 28845578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters